Redefining the future of clinical trials in oncology
The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in this therapy area.
Oncology Clinical Trial Trends in the US
NIH Phase Ib/II DLBCL drug combo trial reports 34% complete response
Tackling trial diversity in a biased clinical development landscape
Genentech experts call for multiple strategies to diversify clinical trials
US West Coast oncology clinical trials lead in diversity
FDA questions efficacy of Amgen’s Lumakras in lung cancer trial
Leap enrols first subject in Phase II colorectal cancer antibody trial
FDA grants IND clearance for Phase I trials of Phanes’ cancer antibody
